This week in gene and cell therapy - 6 April 2018

Gene and cell therapy headlines 2 - 6 April

Optogenetics in combination with local gene therapy restores normal heart rhythm in arrhythmic rats

New CRISPR system CasRx allows more efficient targeting of cellular RNA, tau mis-splicing corrected as proof of concept

EMA approves darvadstrocel by Takeda and TiGenix for Crohn’s disease

FDA grants AstraZeneca's moxetumomab biologics license application priority review